| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0306-3623(01)00079-9 |
| P698 | PubMed publication ID | 11483291 |
| P50 | author | Alan Goldin | Q42884134 |
| P2093 | author name string | Pugsley MK | |
| Yu EJ | |||
| P2860 | cites work | A quantitative description of membrane current and its application to conduction and excitation in nerve | Q22337072 |
| Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel | Q28186859 | ||
| Cardiac sodium channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (mu 1) channels | Q28379079 | ||
| Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif | Q28579493 | ||
| Resurgence of sodium channel research | Q34142210 | ||
| Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction | Q34684384 | ||
| Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289. | Q36330103 | ||
| Kinetic effects of quaternary lidocaine block of cardiac sodium channels: a gating current study | Q36411498 | ||
| Blockade of current through single calcium channels by Cd2+, Mg2+, and Ca2+. Voltage and concentration dependence of calcium entry into the pore | Q36433881 | ||
| Sodium channel inactivation is altered by substitution of voltage sensor positive charges | Q36435941 | ||
| A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation | Q37301303 | ||
| A neutral amino acid change in segment IIS4 dramatically alters the gating properties of the voltage-dependent sodium channel | Q37665790 | ||
| An integrated view of the molecular toxinology of sodium channel gating in excitable cells | Q38173578 | ||
| Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels | Q39707961 | ||
| Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs | Q40110329 | ||
| Structure and function of voltage-dependent sodium channels: comparison of brain II and cardiac isoforms | Q40935493 | ||
| Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line | Q41161442 | ||
| Quantitative analysis of effects of kappa-opioid agonists on postischemic hippocampal CA1 neuronal necrosis in gerbils | Q41336024 | ||
| Lidocaine block of cardiac sodium channels | Q41556598 | ||
| On the molecular nature of the lidocaine receptor of cardiac Na+ channels. Modification of block by alterations in the alpha-subunit III-IV interdomain | Q41679802 | ||
| Primary structure and expression of a sodium channel characteristic of denervated and immature rat skeletal muscle | Q41745813 | ||
| Cardiovascular actions of the κ‐agonist, U‐50,488H, in the absence and presence of opioid receptor blockade | Q42028208 | ||
| Molecular determinants of state-dependent block of Na+ channels by local anesthetics | Q42284240 | ||
| Functional analysis of the rat I sodium channel in xenopus oocytes. | Q42545515 | ||
| Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes | Q42677849 | ||
| PD117302: a selective agonist for the kappa-opioid receptor | Q42849304 | ||
| Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels | Q43489970 | ||
| An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H. | Q44335415 | ||
| Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart--an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis | Q44336625 | ||
| Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury | Q44342356 | ||
| Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives | Q44342759 | ||
| Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agent | Q44346283 | ||
| Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels | Q46817303 | ||
| Preparation of RNA for injection into Xenopus oocytes | Q48588746 | ||
| Lidocaine blockade of continuously and transiently accessible sites in cardiac sodium channels*1 | Q51717818 | ||
| Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion | Q68084734 | ||
| Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat | Q77738084 | ||
| P433 | issue | 6 | |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 417-427 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | General Pharmacology | Q27710984 |
| P1476 | title | Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes | |
| P478 | volume | 34 |
Search more.